Evidence map›Paper›PMID 31936187›Full record

ReviewInternational journal of molecular sciences2020

New Insights into the Biological and Pharmaceutical Properties of Royal Jelly.

Saboor Ahmad, Maria Graça Campos, Filippo Fratini, Solomon Zewdu Altaye, Jianke Li

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed
29.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 248 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Saboor AhmadKey Laboratory of Pollinating Insect Biology, Ministry of Agriculture, Institute of Apicultural Research, Chinese Academy of Agricultural Sciences, Beijing 100081, China.
Maria Graça CamposCoimbra Chemistry Centre, (CQC, FCT Unit 313), Faculty of Sciences Technology, University of Coimbra, Rua Larga, 3004-535 Coimbra, Portugal.ORCID 0000-0003-1012-6240
Filippo FratiniDepartment of Veterinary Sciences, University of Pisa, Viale delle Piagge 2, 56124 Pisa, Italy.
Solomon Zewdu AltayeKey Laboratory of Pollinating Insect Biology, Ministry of Agriculture, Institute of Apicultural Research, Chinese Academy of Agricultural Sciences, Beijing 100081, China.
Jianke LiKey Laboratory of Pollinating Insect Biology, Ministry of Agriculture, Institute of Apicultural Research, Chinese Academy of Agricultural Sciences, Beijing 100081, China.
Chinese Academy of Agricultural Sciences · CNUniversity of Coimbra · PTUniversity of Pisa · IT

Funding

RENAL PATHOGENICITY OF ANTIDNA ANTIBODIESK08AR002015 · NIAMS · YESHIVA UNIVERSITY · PI PUTTERMAN, CHAIM · 1997 to 2001
$252k
Agricultural Science and Technology Innovation Program CAAS-ASTIP-2015-IARModern Agro-Industry Technology Research System CARS-44National project for upgrading overall bee-product quality of beekeeping industry of China -
6 · The paper itself

Abstract

Royal jelly (RJ) is a yellowish-white and acidic secretion of hypopharyngeal and mandibular glands of nurse bees used to feed young worker larvae during the first three days and the entire life of queen bees. RJ is one of the most appreciated and valued natural product which has been mainly used in traditional medicines, health foods, and cosmetics for a long time in different parts of the world. It is also the most studied bee product, aimed at unravelling its bioactivities, such as antimicrobial, antioxidant, anti-aging, immunomodulatory, and general tonic action against laboratory animals, microbial organisms, farm animals, and clinical trials. It is commonly used to supplement various diseases, including cancer, diabetes, cardiovascular, and Alzheimer's disease. Here, we highlight the recent research advances on the main bioactive compounds of RJ, such as proteins, peptides, fatty acids, and phenolics, for a comprehensive understanding of the biochemistry, biological, and pharmaceutical responses to human health promotion and life benefits. This is potentially important to gain novel insight into the biological and pharmaceutical properties of RJ.

Indexed as

AnimalsAnti-Bacterial AgentsAnti-Infective AgentsAntioxidantsBeesBiological ProductsCosmeticsFatty AcidsHumansLarvaPharmaceutical PreparationsRoyal JellyAnti-Bacterial AgentsAnti-Infective AgentsAntioxidantsBiological ProductsCosmeticsFatty AcidsPharmaceutical PreparationsRoyal Jellybioactive compoundsfatty acidsfunctional propertiesphenolicsproteinsroyal jelly

Identifiers

PMID31936187
PMCPMC7014095
OpenAlexW3000014045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.